Molecular Insights into the Germline for Prostate Cancer Initiation, Progression, and Aggressiveness

Colin C. Pritchard, MD, PhD, director of the Genetics and Solid Tumors Laboratory at the University of Washington Medical Center, discusses how germline testing and next-generation sequencing (NGS) of tumors have become important for guiding prostate cancer diagnosis, treatment, and assessment of risk. He details DNA damage response (DDR) genes, including key pathways, potential risk factors, and general characteristics. He also discusses the role of molecular pathologists in testing samples, choosing methodology, and interpreting results.

Read More